These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33359140)

  • 1. Evaluation of the effects of the T-type calcium channel enhancer SAK3 in a rat model of TAF1 deficiency.
    Dhanalakshmi C; Janakiraman U; Moutal A; Fukunaga K; Khanna R; Nelson MA
    Neurobiol Dis; 2021 Feb; 149():105224. PubMed ID: 33359140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The investigation of the T-type calcium channel enhancer SAK3 in an animal model of TAF1 intellectual disability syndrome.
    Janakiraman U; Dhanalakshmi C; Yu J; Moutal A; Boinon L; Fukunaga K; Khanna R; Nelson MA
    Neurobiol Dis; 2020 Sep; 143():105006. PubMed ID: 32622085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TAF1-gene editing alters the morphology and function of the cerebellum and cerebral cortex.
    Janakiraman U; Yu J; Moutal A; Chinnasamy D; Boinon L; Batchelor SN; Anandhan A; Khanna R; Nelson MA
    Neurobiol Dis; 2019 Dec; 132():104539. PubMed ID: 31344492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-type calcium channel enhancer SAK3 produces anti-depressant-like effects by promoting adult hippocampal neurogenesis in olfactory bulbectomized mice.
    Xu J; Yabuki Y; Yu M; Fukunaga K
    J Pharmacol Sci; 2018 Aug; 137(4):333-341. PubMed ID: 30196018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The T-type calcium channel enhancer SAK3 inhibits neuronal death following transient brain ischemia via nicotinic acetylcholine receptor stimulation.
    Yabuki Y; Jing X; Fukunaga K
    Neurochem Int; 2017 Sep; 108():272-281. PubMed ID: 28457878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of SAK3, a novel T-type voltage-gated Ca
    Yabuki Y; Matsuo K; Izumi H; Haga H; Yoshida T; Wakamori M; Kakei A; Sakimura K; Fukuda T; Fukunaga K
    Neuropharmacology; 2017 May; 117():1-13. PubMed ID: 28093211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-type calcium channel enhancer SAK3 promotes dopamine and serotonin releases in the hippocampus in naive and amyloid precursor protein knock-in mice.
    Wang S; Yabuki Y; Matsuo K; Xu J; Izumi H; Sakimura K; Saito T; Saido TC; Fukunaga K
    PLoS One; 2018; 13(12):e0206986. PubMed ID: 30571684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Administration of the T-Type Calcium Channel Enhancer SAK3 Reduces Oxidative Stress and Improves Cognition in Olfactory Bulbectomized Mice.
    Yuan D; Cheng A; Kawahata I; Izumi H; Xu J; Fukunaga K
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of T-type Calcium Channels in Regulating Neuronal Function].
    Yabuki Y
    Yakugaku Zasshi; 2020; 140(10):1207-1212. PubMed ID: 32999199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-Type Ca
    Xu J; Kawahata I; Izumi H; Fukunaga K
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAF1, associated with intellectual disability in humans, is essential for embryogenesis and regulates neurodevelopmental processes in zebrafish.
    Gudmundsson S; Wilbe M; Filipek-Górniok B; Molin AM; Ekvall S; Johansson J; Allalou A; Gylje H; Kalscheuer VM; Ledin J; Annerén G; Bondeson ML
    Sci Rep; 2019 Jul; 9(1):10730. PubMed ID: 31341187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TAF1 Variants Are Associated with Dysmorphic Features, Intellectual Disability, and Neurological Manifestations.
    O'Rawe JA; Wu Y; Dörfel MJ; Rope AF; Au PY; Parboosingh JS; Moon S; Kousi M; Kosma K; Smith CS; Tzetis M; Schuette JL; Hufnagel RB; Prada CE; Martinez F; Orellana C; Crain J; Caro-Llopis A; Oltra S; Monfort S; Jiménez-Barrón LT; Swensen J; Ellingwood S; Smith R; Fang H; Ospina S; Stegmann S; Den Hollander N; Mittelman D; Highnam G; Robison R; Yang E; Faivre L; Roubertie A; Rivière JB; Monaghan KG; Wang K; Davis EE; Katsanis N; Kalscheuer VM; Wang EH; Metcalfe K; Kleefstra T; Innes AM; Kitsiou-Tzeli S; Rosello M; Keegan CE; Lyon GJ
    Am J Hum Genet; 2015 Dec; 97(6):922-32. PubMed ID: 26637982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taf1 knockout is lethal in embryonic male mice and heterozygous females show weight and movement disorders.
    Crombie EM; Korecki AJ; Cleverley K; Adair BA; Cunningham TJ; Lee WC; Lengyell TC; Maduro C; Mo V; Slade LM; Zouhair I; Fisher EMC; Simpson EM
    Dis Model Mech; 2024 Jul; 17(7):. PubMed ID: 38804708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAK3 Administration Improves Spine Abnormalities and Cognitive Deficits in App
    Izumi H; Kawahata I; Shinoda Y; Helmstetter FJ; Fukunaga K
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32481611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-type Ca
    Degawa T; Kawahata I; Izumi H; Shinoda Y; Fukunaga K
    J Pharmacol Sci; 2021 May; 146(1):1-9. PubMed ID: 33858649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute Treatment with T-Type Calcium Channel Enhancer SAK3 Reduces Cognitive Impairments Caused by Methimazole-Induced Hypothyroidism Via Activation of Cholinergic Signaling.
    Husain N; Yabuki Y; Shinoda Y; Fukunaga K
    Pharmacology; 2018; 101(5-6):309-321. PubMed ID: 29597200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intellectual disability and dysmorphic features in male siblings arising from a novel TAF1 mutation.
    Okamoto N; Arai H; Onishi T; Mizuguchi T; Matsumoto N
    Congenit Anom (Kyoto); 2020 Jan; 60(1):40-41. PubMed ID: 30805980
    [No Abstract]   [Full Text] [Related]  

  • 18. Striatal Cholinergic Dysregulation after Neonatal Decrease in X-Linked Dystonia Parkinsonism-Related TAF1 Isoforms.
    Cirnaru MD; Creus-Muncunill J; Nelson S; Lewis TB; Watson J; Ellerby LM; Gonzalez-Alegre P; Ehrlich ME
    Mov Disord; 2021 Dec; 36(12):2780-2794. PubMed ID: 34403156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism.
    Rakovic A; Domingo A; Grütz K; Kulikovskaja L; Capetian P; Cowley SA; Lenz I; Brüggemann N; Rosales R; Jamora D; Rolfs A; Seibler P; Westenberger A; König I; Klein C
    Mov Disord; 2018 Jul; 33(7):1108-1118. PubMed ID: 30153385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
    Petrozziello T; Dios AM; Mueller KA; Vaine CA; Hendriks WT; Glajch KE; Mills AN; Mangkalaphiban K; Penney EB; Ito N; Fernandez-Cerado C; Legarda GPA; Velasco-Andrada MS; Acuña PJ; Ang MA; Muñoz EL; Diesta CCE; Macalintal-Canlas R; Acuña G; Sharma N; Ozelius LJ; Bragg DC; Sadri-Vakili G
    PLoS One; 2020; 15(12):e0243655. PubMed ID: 33315879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.